Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 3, Issue 1, Pages 31-38
http://dx.doi.org/10.1093/ecam/nek010
Review

Role of Toll-like Receptors in Adjuvant-Augmented Immune Therapies

1Department of Microbiology and Immunology, Hokkaido University Graduate School of Medicine, Kita-15, Nishi-7, Kita-ku Sapporo 060-8638, Japan
2Department of Immunogy, Osaka Medical Center for Cancer, Nakamichi 1-3-2, Higashinari-ku, Osaka 537-8511, Japan
3ERATO-JST, Laboratory of Molecular and Developmental Biology, University of Tsukuba, Tennoudai 1-1-1, Tsukuba 305-8577, Japan

Received 3 September 2005

Copyright © 2006 Tsukasa Seya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [52 citations]

The following is the list of published articles that have cited the current article.

  • El Cooper, “Role of TOLL-like receptors in adjuvant-augmented immune therapies by T. Seya,” Evidence-Based Complementary And Alternative Medicine, vol. 3, no. 1, pp. 133–137, 2006. View at Publisher · View at Google Scholar
  • A Vojdani, and J Erde, “Regulatory T cells, a potent immunoregulatory target for CAM researchers: The ultimate antagonist (I),” Evidence-Based Complementary And Alternative Medicine, vol. 3, no. 1, pp. 25–30, 2006. View at Publisher · View at Google Scholar
  • Misako Matsumoto, Miwa Sasai, and Tsukasa Seya, “The kinase complex responsible for IRF-3-mediated IFN-β production in myeloid dendritic cells (mDC),” Journal of Biochemistry, vol. 139, no. 2, pp. 171–175, 2006. View at Publisher · View at Google Scholar
  • Theresia M. Westers, Gert J. Ossenkoppele, and Arjan A. van de Loosdrecht, “Dendritic cell-based immunotherapy in acute and chronic myeloid leukaemia,” Biomedicine & Pharmacotherapy, vol. 61, no. 6, pp. 306–314, 2007. View at Publisher · View at Google Scholar
  • Jianhong Zhang, Rui Sun, Haiming Wei, Dongmei Wu, and Zhigang Tian, “Toll-like receptor 3 agonist enhances IFN-γ and TNF-α production by murine uterine NK cells,” International Immunopharmacology, vol. 7, no. 5, pp. 588–596, 2007. View at Publisher · View at Google Scholar
  • Mohamed L Salem, Mark P Rubinstein, and David J ColeeLS, 2007. View at Publisher · View at Google Scholar
  • Hoornan Izadi, Amirreza T. Motameni, Tonya C. Bates, Elias R. Olivera, Vega Villar-Suarez, Ila Joshi, Renu Garg, Barbara A. Osborne, Roger J. Davis, Mercedes Rincon, and Juan Anguita, “C-Jun N-terminal kinase 1 is required for toll-like receptor 1 gene expression in macrophages,” Infection And Immunity, vol. 75, no. 10, pp. 5027–5034, 2007. View at Publisher · View at Google Scholar
  • Pascale Hubert, Nathalie Jacobs, Jean-Hubert Caberg, Jacques Boniver, and Philippe Delvenne, “The cross-talk between dendritic and regulatory T cells: Good or evil?,” Journal of Leukocyte Biology, vol. 82, no. 4, pp. 781–794, 2007. View at Publisher · View at Google Scholar
  • Sally T. Ishizaka, and Lynn D. Hawkins, “E6020: A synthetic Toll-like receptor 4 agonist as a vaccine adjuvant,” Expert Review of Vaccines, vol. 6, no. 5, pp. 773–784, 2007. View at Publisher · View at Google Scholar
  • Sally T. Ishizaka, and Lynn D. Hawkins, “E6020: a synthetic Toll-like receptor 4 agonist as a vaccine adjuvant,” Expert Review of Vaccines, vol. 6, no. 5, pp. 773–784, 2007. View at Publisher · View at Google Scholar
  • Bethany M. Tesar, Hua Shen, Wendy E. Walker, and Daniel R. Goldstein, “Dual signaling of MyD88 and TRIF is critical for maximal TLR4-induced dendritic cell maturation,” Journal of Immunology, vol. 181, no. 3, pp. 1849–1858, 2008. View at Publisher · View at Google Scholar
  • Kim S. Jones, “Biomaterials as vaccine adjuvants,” Biotechnology Progress, vol. 24, no. 4, pp. 807–814, 2008. View at Publisher · View at Google Scholar
  • Elizabeth W. Uhl, Marcus Martin, James K. Coleman, and Janet K. Yamamoto, “Advances in FIV vaccine technology,” Veterinary Immunology and Immunopathology, vol. 123, no. 1-2, pp. 65–80, 2008. View at Publisher · View at Google Scholar
  • Misako Matsumoto, and Tsukasa Seya, “TLR3: Interferon induction by double-stranded RNA including poly(I : C),” Advanced Drug Delivery Reviews, vol. 60, no. 7, pp. 805–812, 2008. View at Publisher · View at Google Scholar
  • Liying Chen, and Mikael Jondal, “Brefeldin A inhibits vesicular MHC class I processing in resting but not in CpG- and disruption-activated DC,” Molecular Immunology, vol. 46, no. 1, pp. 158–165, 2008. View at Publisher · View at Google Scholar
  • L. M. Pletneva, O. Haller, D. D. Porter, G. A. Prince, and J. C. G. Blanco, “Induction of type I interferons and interferon-inducible Mx genes during respiratory syncytial virus infection and reinfection in cotton rats,” Journal of General Virology, vol. 89, no. 1, pp. 261–270, 2008. View at Publisher · View at Google Scholar
  • Hyeon-Sook Suh, Meng-Liang Zhao, Namjong Choi, Thomas J. Belbin, Celia F. Brosnan, and Sunhee C. Lee, “TLR3 and TLR4 are innate antiviral immune receptors in human microglia: Role of IRF3 in modulating antiviral and inflammatory response in the CNS,” Virology, vol. 392, no. 2, pp. 246–259, 2009. View at Publisher · View at Google Scholar
  • Ying Ding, See Voon Seow, Chiung Hui Huang, Lee Mei Liew, Yaw Chyn Lim, I. Chun Kuo, and Kaw Yan Chua, “Coadministration of the fungal immunomodulatory protein FIP-Fve and a tumour-associated antigen enhanced antitumour immunity,” Immunology, vol. 128, no. 1pt2, pp. e881–e894, 2009. View at Publisher · View at Google Scholar
  • R. B. Mandell, R. Flick, W. R. Staplin, L. D. Kaniewski, A. K. Carzoli, R. P. Manuszak, J. Wang, G. R. Rossi, N. N. Vahanian, and C. J. Link, “ The αGal HyperAcute ® Technology: Enhancing Immunogenicity of Antiviral Vaccines by Exploiting the Natural αGal-Mediated Zoonotic Blockade ,” Zoonoses and Public Health, vol. 56, no. 6-7, pp. 391–406, 2009. View at Publisher · View at Google Scholar
  • Michelle Yong, Daniel Mitchell, Audrey Caudron, Istvan Toth, and Colleen Olive, “Expression of maturation markers on murine dendritic cells in response to group A streptococcal lipopeptide vaccines,” Vaccine, vol. 27, no. 25-26, pp. 3313–3318, 2009. View at Publisher · View at Google Scholar
  • Michel M. Van den Heuvel, Sjaak A. Burgers, and Nico van Zandwijk, “Immunotherapy in Non–Small-Cell Lung Carcinoma: From Inflammation to Vaccination,” Clinical Lung Cancer, vol. 10, no. 2, pp. 99–105, 2009. View at Publisher · View at Google Scholar
  • Adrián Vilalta, Mark Shlapobersky, Qun Wei, Rodrick Planchon, Alain Rolland, and Sean Sullivan, “Analysis of biomarkers after intramuscular injection of Vaxfectin®-formulated hCMV gB plasmid DNA,” Vaccine, vol. 27, no. 52, pp. 7409–7417, 2009. View at Publisher · View at Google Scholar
  • A. A. van de Loosdrecht, W. van den Ancker, I. Houtenbos, G. J. Ossenkoppele, and T. M. Westers, “Dendritic Cell-Based Immunotherapy in Myeloid Leukaemia: Translating Fundamental Mechanisms into Clinical Applications,” Dendritic Cells, vol. 188, pp. 319–348, 2009. View at Publisher · View at Google Scholar
  • Van De Loosdrecht, Van Den Ancker, Houtenbos, Ossenkoppele, and Westers, “Dendritic cell-based immunotherapy in myeloid leukaemia: Translating fundamental mechanisms into clinical applications,” Handbook of Experimental Pharmacology, vol. 188, pp. 319–348, 2009. View at Publisher · View at Google Scholar
  • Mohamed Labib Salem, “The potential use of dendritic cell-based immunotherapy for treatment of pancreatic cancer,” Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry, vol. 9, no. 4, pp. 191–202, 2009. View at Publisher · View at Google Scholar
  • Takashi Akazawa, Norimitsu Inoue, Hiroaki Shime, Ken Kodama, Misako Matsumoto, and Tsukasa Seya, “Adjuvant engineering for cancer immunotherapy: Development of a synthetic TLR2 ligand with increased cell adhesion,” Cancer Science, vol. 101, no. 7, pp. 1596–1603, 2010. View at Publisher · View at Google Scholar
  • Yifan Ma, Louis Poisson, Guzman Sanchez-Schmitz, Santosh Pawar, Chunfeng Qu, Gwendalyn J. Randolph, William L. Warren, Eric M. Mishkin, and Russell G. Higbee, “Assessing the immunopotency of Toll-like receptor agonists in an in vitro tissue-engineered immunological model,” Immunology, vol. 130, no. 3, pp. 374–387, 2010. View at Publisher · View at Google Scholar
  • Tsukasa Seya, Hiroaki Shime, Takashi Ebihara, Hiroyuki Oshiumi, and Misako Matsumoto, “Pattern recognition receptors of innate immunity and their application to tumor immunotherapy,” Cancer Science, vol. 101, no. 2, pp. 313–320, 2010. View at Publisher · View at Google Scholar
  • Mohamed L. Salem, Maha EL-Demellawy, and Abdel Raouf Abou El-Azm, “The potential use of Toll-like receptor agonists to restore the dysfunctional immunity induced by hepatitis C virus,” Cellular Immunology, vol. 262, no. 2, pp. 96–104, 2010. View at Publisher · View at Google Scholar
  • Willemijn van den Ancker, Marvin M van Luijn, Theresia M Westers, Hetty J Bontkes, Jurjen M Ruben, Tanja D de Gruijl, Gert J Ossenkoppele, and Arjan A van de Loosdrecht, “Recent advances in antigen-loaded dendritic cell-based strategies for treatment of minimal residual disease in acute myeloid leukemia,” Immunotherapy, vol. 2, no. 1, pp. 69–83, 2010. View at Publisher · View at Google Scholar
  • Gnieszka AJezierska, Irina A. Kolosova, and Alexander D. Verin, “Toll like receptors signaling pathways as a target for therapeutic interventions,” Current Signal Transduction Therapy, vol. 6, no. 3, pp. 428–440, 2011. View at Publisher · View at Google Scholar
  • Ni Li, Li-Hua Peng, Xi Chen, Shinsaku Nakagawa, and Jian-Qing Gao, “Transcutaneous vaccines: Novel advances in technology and delivery for overcoming the barriers,” Vaccine, vol. 29, no. 37, pp. 6179–6190, 2011. View at Publisher · View at Google Scholar
  • Mohamed Labib Salem, “Triggering of toll-like receptor signaling pathways in T cells contributes to the anti-tumor efficacy of T cell responses,” Immunology Letters, vol. 137, no. 1-2, pp. 9–14, 2011. View at Publisher · View at Google Scholar
  • A. Raja, A.R. Vignesh, B. Ann Mary, K.G. Tirumurugaan, G. Dhinakar Raj, Ranjith Kataria, B.P. Mishra, and K. Kumanan, “Sequence analysis of Toll-like receptor genes 1–10 of goat (Capra hircus),” Veterinary Immunology and Immunopathology, vol. 140, no. 3-4, pp. 252–258, 2011. View at Publisher · View at Google Scholar
  • Ni Li, Li-Hua Peng, Xi Chen, Shinsaku Nakagawa, and Jian-Qing Gao, “Effective transcutaneous immunization by antigen-loaded flexible liposome in vivo,” International Journal Of Nanomedicine, vol. 6, pp. 3241–3250, 2011. View at Publisher · View at Google Scholar
  • Dipshikha Chakravortty, Amit Lahiri, and Priyanka Das, “Toll Receptors in Relation to Adjuvant Effects,” Vaccinology, pp. 393–400, 2012. View at Publisher · View at Google Scholar
  • L. M. Skivka, Yu. V. Shvets, N. M. Khranovska, O. G. Fedorchuk, V. V. Pozur, and N. V. Senchilo, “Synergistic effect of microbe-associated molecules on human monocyte-derived dendritic cell maturation in vitro,” Biopolymers and Cell, vol. 28, no. 1, pp. 50–55, 2012. View at Publisher · View at Google Scholar
  • Sheena H. Wang, Afton L. Thompson, Anthony J. Hickey, and Herman F. Staats, “Dry Powder Vaccines for Mucosal Administration: Critical Factors in Manufac ture and Delivery,” Mucosal Vaccines: Modern Concepts, Strategies, and Challenges, vol. 354, pp. 121–156, 2012. View at Publisher · View at Google Scholar
  • Josias Brito Frazão, Paolo Ruggero Errante, and Antonio Condino-Neto, “Toll-Like Receptors’ Pathway Disturbances are Associated with Increased Susceptibility to Infections in Humans,” Archivum Immunologiae et Therapiae Experimentalis, 2013. View at Publisher · View at Google Scholar
  • C Bryce Johnson, Mohamed L Salem, Shikhar Mehrotra, David J Cole, and Mark P RubinsteineLS, 2013. View at Publisher · View at Google Scholar
  • Sachiko Hirobe, Naoki Okada, and Shinsaku Nakagawa, “Transcutaneous vaccines – current and emerging strategies,” Expert Opinion on Drug Delivery, vol. 10, no. 4, pp. 485–498, 2013. View at Publisher · View at Google Scholar
  • Yu Zhou, Wenzhe Ho, Ming Guo, Xu Wang, Jielang Li, Yizhong Wang, Li Ye, Ming Dai, Li Zhou, and Yuri Persidsky, “TLR3 activation efficiency by high or low molecular mass poly I:C,” Innate Immunity, vol. 19, no. 2, pp. 184–192, 2013. View at Publisher · View at Google Scholar
  • Qi Lu, Hao Ding, and Weiping Li, “Role of Toll-like receptors in microbiota-associated gastrointestinal cancer metastasis,” Journal of Cancer Research and Therapeutics, vol. 9, no. 7, pp. S142–S149, 2013. View at Publisher · View at Google Scholar
  • Mohamed L. Salem, “The use of dendritic cells for peptide-based vaccination in cancer immunotherapy,” Methods in Molecular Biology, vol. 1139, pp. 479–503, 2014. View at Publisher · View at Google Scholar
  • C Salazar, D Haussmann, G Kausel, and J Figueroa, “ Molecular cloning of Salmo salar Toll-like receptors (TLR1, TLR22, TLR5M and TLR5S) and expression analysis in SHK-1 cells during Piscirickettsia salmonis infection ,” Journal of Fish Diseases, 2015. View at Publisher · View at Google Scholar
  • B. Peña, A. Isla, D. Haussmann, and J. Figueroa, “Immunostimulatory effect of salmon prolactin on expression of Toll-like receptors in Oncorhynchus mykiss infected with Piscirickettsia salmonis,” Fish Physiology and Biochemistry, 2015. View at Publisher · View at Google Scholar
  • Shoichi Takagi, Yuki Takahashi, Kanako Sugimura, Makiya Nishikawa, and Yoshinobu Takakura, “Application of Magnesium Pyrophosphate–Based Sponge-Like Microparticles to Enhance the Delivery Efficiency and Adjuvant Effects of Polyriboinosinic-Polyribocytidylic Acid in Immune Cells,” Journal of Pharmaceutical Sciences, vol. 105, no. 2, pp. 766–772, 2016. View at Publisher · View at Google Scholar
  • Monika Kaurav, Sunita Minz, Kantrol Sahu, Manoj Kumar, Jitender Madan, and Ravi Shankar Pandey, “Nanoparticulate mediated transcutaneous immunization: Myth or reality,” Nanomedicine: Nanotechnology, Biology and Medicine, 2016. View at Publisher · View at Google Scholar
  • Daisuke Fujikura, Daisuke Muramatsu, Kochi Toyomane, Satoko Chiba, Takuji Daito, Atsushi Iwai, Takahisa Kouwaki, Masaaki Okamoto, Hideaki Higashi, Hiroshi Kida, and Hiroyuki Oshiumi, “Aureobasidium pullulans-cultured fluid induces IL-18 production, leading to Th1-polarization during influenza A virus infection,” The Journal of Biochemistry, 2017. View at Publisher · View at Google Scholar
  • Naru Zhang, and Kutty Selva Nandakumar, “Recent advances in the development of vaccines for chronic inflammatory autoimmune diseases,” Vaccine, 2018. View at Publisher · View at Google Scholar
  • Zongmin Zhao, Brian Harris, Yun Hu, Theresa Harmon, Paul R. Pentel, Marion Ehrich, and Chenming Zhang, “Rational incorporation of molecular adjuvants into a hybrid nanoparticle-based nicotine vaccine for immunotherapy against nicotine addiction,” Biomaterials, vol. 155, pp. 165–175, 2018. View at Publisher · View at Google Scholar
  • P.N. Shivakumara, T.V. Aravindakshan, Thomas Naicy, K. Anilkumar, and R. Uma, “Molecular characterization and differential mRNA expression profiling of Toll - like receptor - 2 gene in Vechur ( Bos indicus ) and crossbred ( Bos indicus X Bos taurus ) cattle of Kerala in response to anthrax vaccination,” Meta Gene, 2018. View at Publisher · View at Google Scholar